Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-6405
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Incidence and predictors of early loss to follow up among patients initiated on protease inhibitor-based second-line antiretroviral therapy in southwestern Uganda ; volume:18 ; number:1 ; day:20 ; month:3 ; year:2021 ; pages:1-9 ; date:12.2021
AIDS research and therapy ; 18, Heft 1 (20.3.2021), 1-9, 12.2021
- Creator
-
Nuwagira, Edwin
Lumori, Boniface A. E.
Muhindo, Rose
Kanyesigye, Michael
Amir, Abdallah
Muyindike, Winnie
Muzoora, Conrad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12981-021-00331-5
- URN
-
urn:nbn:de:101:1-2021050614545877517857
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nuwagira, Edwin
- Lumori, Boniface A. E.
- Muhindo, Rose
- Kanyesigye, Michael
- Amir, Abdallah
- Muyindike, Winnie
- Muzoora, Conrad
- SpringerLink (Online service)
Other Objects (12)
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
Immune reconstitution inflammatory syndrome (IRIS) in HIV positive patients initiated on antiretroviral therapy (ART)
Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa
Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
Immune reconstitution inflammatory syndrome (IRIS) in HIV positive patients initiated on antiretroviral therapy (ART)
Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa
Depression is associated with efavirenz-containing treatments in newly antiretroviral therapy initiated HIV patients in Ecuador
HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting
Virologic outcomes of second-line antiretroviral therapy in Eastern European country of Georgia
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Virological failure among people living with HIV receiving second-line antiretroviral therapy in Pune, India
Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India
Immune reconstitution inflammatory syndrome (IRIS) in HIV positive patients initiated on antiretroviral therapy (ART)
Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa